Denosumab vs zoledronic acid: which is best in the real world?

Two common drug therapies for osteoporosis are equally safe and effective, according to a real-world study.

US data from 2,500 matched pairs of patients starting on either denosumab or zoledronic acid showed similar rates of infection, cardiovascular events and osteoporotic fracture over the first year of treatment.